"The commercial market has grown faster than the clinical evidence base," the paper read, and "the absence of adequate clinical evidence for use in humans is an alarming safety concern." Rita Jew, the ISMP president, told AFP "there's no new information that will make us feel comfortable" that the seven peptides should be authorizied for compounding
Schedule your plantar fasciitis consultation today and discover how PRP & acoustic wave therapy can get you back to the trails, roads, and races that make Minnesota running so special
For patients pursuing a hair-density protocol, GHK-Cu is a natural addition to platelet-rich plasma injections or in-office topical treatments
Both peptides are recognized for their distinctive properties and their potential roles in cellular tissue regeneration
While topical application is convenient and non-invasive, the peptide faces a significant barrier: human skin is designed to keep foreign substances out
The 12-week mark aligns with what clinical GHK-Cu skin trials use as their primary endpoint, and the published results from those trials reflect what researchers running systematic protocols report: clear, documented improvement in skin architecture
